Spaltro G, et al. Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesis. Cytotherapy. 2015;17:1302–1313.
PAX ADVANCED THERAPIES / NEWS
Advancing the Conversation
Stay informed about company developments, technology updates, scientific insights, and future initiatives.
01 / NEWS
News & Publications
Company News
Announcements and milestones.
Scientific Updates
Research developments and educational content.
Industry Insights
Trends shaping regenerative medicine and biotechnology.
Events & Presentations
Conferences, meetings, and speaking engagements.
Company announcements and publications will be added here as they become available.
02 / PUBLICATIONS
Impactful Journal Articles
A selection of peer-reviewed publications informing the scientific foundation of PBMC-based regenerative therapies and point-of-care cell concentration technologies.
Rehak L, et al. The immune-centric revolution translated into clinical application: peripheral blood mononuclear cell (PBMNC) therapy in diabetic patients with no-option critical limb-threatening ischemia (NO-CLTI)—rationale and meta-analysis of observational studies. Journal of Clinical Medicine. 2024;13(23):7230.
Scatena A, et al. Autologous peripheral blood mononuclear cells for limb salvage in diabetic foot patients with no-option critical limb ischemia. Journal of Clinical Medicine. 2021;10(10):2213.
Panunzi A, et al. Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers. Cardiovascular Diabetology. 2022;21:196.
Meloni M, et al. Long-term outcomes of autologous cell therapy in patients with ischaemic diabetic foot ulcers and no-option chronic limb threatening ischaemia. Acta Diabetologica. 2026;63:1447–1457.
De Angelis B, et al. Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers. Tissue Engineering Part C: Methods. 2015;21:423–435.
Meloni M, et al. Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cells. Acta Diabetologica. 2025;62:1907–1913.
Scala P, et al. Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts. Heliyon. 2023;9(6):e17141.
Scala P, et al. Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts. Frontiers in Bioengineering and Biotechnology. 2023;10:1075715.
DOI links resolve to the publisher record. Listings are provided for educational reference and do not constitute endorsement by PAX Advanced Therapies.
